妇科疾病影像学(19):胃肠外间质瘤的临床与超声特征
eGIST通常表现为较大的实性、分叶状盆腔或腹部肿瘤,回声不均匀,血流丰富且无后方声影,超声报告多将其归为恶性病变,特异性诊断eGIST是最常见的鉴别诊断。
要点
- eGIST多为腹腔内实性肿瘤,中位最大径79mm,分叶状或不规则形。
- 88.6%肿瘤血流丰富(彩色评分3或4分),88.6%无后方声影。
- 超声报告中91.4%的eGIST被正确归类为恶性病变。
核心结论
- 超声上eGIST通常为实性、回声不均匀的盆腔或腹部肿瘤,呈分叶状,伴或不伴囊性区,血流丰富且无后方声影。
- 肿瘤具备上述特征、与肠壁无连接且非源于子宫或附件时,应高度怀疑eGIST。
研究设计与样本
- 回顾性多中心研究,检索9家欧洲大型妇科肿瘤中心数据库中经组织学确诊且术前行超声检查的eGIST患者资料。
主要发现
- 17例为偶然发现,18例有症状;中位年龄57岁(范围21-85岁)。
- 32例(91.4%)为腹腔内病变,2例(5.7%)为腹膜后,1例(2.9%)为腹膜前;最常见部位为腹部(23例,65.7%),其次为盆腔(12例,34.3%)。
- 肿瘤通常较大(中位最大径79mm),31例(88.6%)为实性,4例(11.4%)为多房实性。
- 实性肿瘤中8/31(25.8%)回声均匀且均为低回声;23例回声不均匀,其中9/23(39.1%)为混合回声,14/23(60.9%)含囊性区。
- 形态主要为分叶状(19例,54.3%)或不规则形(10例,28.6%);31例(88.6%)彩色评分3或4分,31例(88.6%)无后方声影。
关键数值与推荐
- 23例(65.7%)检测了CA 125,中位水平23 U/mL(范围7-403 U/mL)。
- 超声报告基于模式识别将32例(91.4%)eGIST正确归类为恶性病变。
- 特异性诊断eGIST是最常见的鉴别诊断(16例,45.7%),其次为原发性卵巢癌(5例,14.3%)、淋巴瘤(2例,5.7%)和带蒂子宫肌瘤(2例,5.7%)。
临床怎么用
- 对于盆腔或腹部实性、回声不均匀、分叶状、血流丰富且无后方声影的肿瘤,尤其与肠壁无连接且非源于子宫或附件时,应将eGIST纳入鉴别诊断。
- 超声检查时可依据国际卵巢肿瘤分析(IOTA)和子宫形态超声评估(MUSA)术语描述病变特征,以提高诊断准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the clinical and sonographic characteristics of extragastrointestinal stromal tumors (eGISTs). METHODS: This was a retrospective multicenter study. The data of patients with a histological diagnosis of eGIST who had undergone preoperative ultrasound examination were retrieved from the databases of nine large European gynecologic oncology centers. One investigator from each center reviewed stored images and ultrasound reports, and described the lesions using the terminology of the International Ovarian Tumor Analysis and Morphological Uterus Sonographic Assessment groups, following a predefined ultrasound evaluation form. Clinical, surgical and pathological information was also recorded. RESULTS: Thirty-five women with an eGIST were identified; in 17 cases, the findings were incidental, and 18 cases were symptomatic. Median age was 57 years (range, 21-85 years). Tumor marker CA 125 was available in 23 (65.7%) patients, with a median level of 23 U/mL (range, 7-403 U/mL). The vast majority of eGISTs were intraperitoneal lesions (n = 32 (91.4%)); the remaining lesions were retroperitoneal (n = 2 (5.7%)) or preperitoneal (n = 1 (2.9%)). The most common site of the tumor was the abdomen (n = 23 (65.7%)), and less frequently the pelvis (n = 12 (34.3%)). eGISTs were typically large (median largest diameter, 79 mm) solid (n = 31 (88.6%)) tumors, and were less frequently multilocular-solid tumors (n = 4 (11.4%)). The echogenicity of solid tumors was uniform in 8/31 (25.8%) cases, which were all hypoechogenic. Twenty-three solid eGISTs were non-uniform, either with mixed echogenicity (9/23 (39.1%)) or with cystic areas (14/23 (60.9%)). The tumor shape was mainly lobular (n = 19 (54.3%)) or irregular (n = 10 (28.6%)). Tumors were typically richly vascularized (color score of 3 or 4, n = 31 (88.6%)) with no shadowing (n = 31 (88.6%)). Based on pattern recognition, eGISTs were usually correctly classified as a malignant lesion in the ultrasound reports (n = 32 (91.4%)), and the specific diagnosis of eGIST was the most frequent differential diagnosis (n = 16 (45.7%)), followed by primary ovarian cancer (n = 5 (14.3%)), lymphoma (n = 2 (5.7%)) and pedunculated uterine fibroid (n = 2 (5.7%)). CONCLUSIONS: On ultrasound, eGISTs were usually solid, non-uniform pelvic or abdominal lobular tumors of mixed echogenicity, with or without cystic areas, with rich vascularization and no shadowing. The presence of a tumor with these features, without connection to the bowel wall, and not originating from the uterus or adnexa, is highly suspicious for eGIST. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Ambrosio M, Testa AC, Moro F, et al. Imaging in gynecological disease (19): clinical and ultrasound features of extragastrointestinal stromal tumors (eGIST). Ultrasound Obstet Gynecol. 2020. PMID: 31909545. doi:10.1002/uog.21968
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。